84.03

2.35% -2.0226

Lemaitre Vascular Inc (LMAT)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Lemaitre Vascular Inc stock is traded at $84.03, with a volume of 66,875. It is down -2.35% in the last 24 hours and down -2.60% over the past month. LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Previous Close:

$86.05

Open:

$86.12

24h Volume:

66,875

Relative Volume:

0.41

Market Cap:

$1.91B

Revenue:

$213.03M

Net Income/Loss:

$41.32M

P/E Ratio:

45.92

EPS:

1.83

Net Cash Flow:

$33.49M

1W Performance:

+1.30%

1M Performance:

-2.60%

6M Performance:

+0.75%

1Y Performance:

-18.01%

1-Day Range:

$83.60

$86.96

1-Week Range:

$81.60

$86.96

52-Week Range:

$71.42

$105.55

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Name

Lemaitre Vascular Inc

Sector

Healthcare (1138)

Industry

Medical Instruments & Supplies (58)

Phone

781-221-2266

Address

63 SECOND AVENUE, BURLINGTON, MA

Employee

664

Twitter

@LMAT_Vascular

Next Earnings Date

2025-02-24

Latest SEC Filings

LMAT's Discussions on Twitter

Compare LMAT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LMAT Lemaitre Vascular Inc	84.07	1.94B	213.03M	41.32M	33.49M	1.83
ISRG Intuitive Surgical Inc	571.23	201.58B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	194.28	55.30B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.90	38.80B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	257.24	36.71B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	280.23	20.27B	2.96B	487.70M	344.00M	6.6758

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-06-25	Upgrade	Barrington Research	Mkt Perform → Outperform
Feb-28-25	Downgrade	Barrington Research	Outperform → Mkt Perform
Feb-28-25	Downgrade	Oppenheimer	Outperform → Perform
Feb-13-25	Initiated	Wells Fargo	Equal Weight
Oct-15-24	Initiated	Cantor Fitzgerald	Neutral
Aug-02-24	Resumed	Lake Street	Buy
May-31-24	Resumed	ROTH MKM	Buy
Apr-26-24	Upgrade	Stifel	Hold → Buy
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-06-23	Initiated	Oppenheimer	Outperform
Aug-03-23	Downgrade	Jefferies	Buy → Hold
May-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-28-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-16-21	Initiated	Jefferies	Buy
Feb-12-21	Initiated	KeyBanc Capital Markets	Sector Weight
Mar-16-20	Upgrade	Sidoti	Neutral → Buy
Oct-24-19	Downgrade	First Analysis Sec	Strong Buy → Outperform
Oct-24-19	Upgrade	Lake Street	Hold → Buy
Oct-14-19	Upgrade	First Analysis Sec	Outperform → Strong Buy
Jul-25-19	Reiterated	Barrington Research	Outperform
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Outperform
Oct-08-18	Upgrade	Barrington Research	Mkt Perform → Outperform
Oct-08-18	Upgrade	ROTH Capital	Neutral → Buy
Jun-08-18	Resumed	ROTH Capital	Buy
Apr-26-18	Downgrade	Stifel	Buy → Hold
Apr-26-18	Upgrade	The Benchmark Company	Hold → Buy
Oct-27-17	Downgrade	First Analysis Sec	Overweight → Equal-Weight
Oct-27-17	Downgrade	The Benchmark Company	Buy → Hold
Jul-10-17	Downgrade	Canaccord Genuity	Buy → Hold
Jul-10-17	Downgrade	The Benchmark Company	Buy → Hold
Mar-21-17	Initiated	First Analysis Sec	Overweight
Feb-22-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-22-16	Downgrade	Sidoti	Buy → Neutral
Jul-28-16	Reiterated	Barrington Research	Outperform
Feb-25-16	Reiterated	Barrington Research	Outperform

View All

Lemaitre Vascular Inc Stock (LMAT) Latest News

07:06 AM

Quantbot Technologies LP Increases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

07:06 AM

Dec 04, 2025

Will LeMaitre Vascular Inc. (LHU) stock keep high P E multiplesWeekly Trade Report & Detailed Earnings Play Strategies - Newser

Dec 04, 2025

Will LeMaitre Vascular Inc. stock benefit from AI adoptionWeekly Trade Recap & High Return Trade Opportunity Guides - Newser

Dec 04, 2025

Why LeMaitre Vascular Inc. (LHU) stock signals breakout potentialTrade Performance Summary & High Win Rate Trade Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Will LeMaitre Vascular Inc. (LHU) stock enhance shareholder value2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser

Dec 03, 2025

Will LeMaitre Vascular Inc. stock outperform value stocks2025 Key Highlights & High Conviction Investment Ideas - Newser

Dec 03, 2025

Is LeMaitre Vascular Inc. (LHU) stock attractive post correctionDollar Strength & Long-Term Capital Growth Strategies - Newser

Dec 03, 2025

Dec 02, 2025

Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve - Yahoo Finance

Dec 02, 2025

Is LeMaitre Vascular Inc. (LHU) stock good for wealth creation - Newser

Dec 02, 2025

Dec 01, 2025

Inceptionr LLC Buys New Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Dec 01, 2025

Russell Investments Group Ltd. Cuts Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Dec 01, 2025

Grandeur Peak Global Advisors LLC Invests $6.28 Million in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Dec 01, 2025

Nov 30, 2025

Is LeMaitre Vascular’s Drop an Opportunity After Expansion and Regulatory News? - Yahoo Finance

Nov 30, 2025

LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness - Yahoo Finance

Nov 30, 2025